CAR-T cell
CAR-T cell is a pharmaceutical drug with 8 clinical trials. Currently 4 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
4
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
A Study of CAR-T Cells in Subjects With Autoimmune Diseases
A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus
Clinical Trials (8)
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
A Study of CAR-T Cells in Subjects With Autoimmune Diseases
A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus
A Study of CAR-T Cells in Subjects with Autoimmune Diseases
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8